BN Business News
Add your company to Business Communicator →

Konkurencja i konsument · 15/11/2016

Valeant Pharmaceuticals International, Inc. Reaches Settlement with Federal Regulators Over Alleged Unfair Competition

Valeant Pharmaceuticals International, Inc. has agreed to a consent order to settle allegations of violating federal law prohibiting unfair methods of competition, as outlined in the attached Analysis to Aid Public Comment.

Source: Federal Register — Federal Trade CommissionOpen original release →